10722951 · Active · incorporated 9 years, 5 months ago · Cambridge
Biotech AI Biotech & Life Sciences Diagnostics Drug Discovery Series A
Mursla Bio develops an AI precision medicine platform using extracellular vesicles for diagnostics, particularly for liver cancer.
Mursla Bio is a private limited company registered at Companies House under number 10722951, incorporated on 12 April 2017, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 106 filings for this company, including 7 funding rounds. Its most recent round closed in May 2026, raising £986k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | May 2026 | £986k | £425.00 |
| Round 6 | Apr 2025 | £762k | £425.00 |
| Round 5 | Sep 2024 | £932k | £425.00 |
| Round 4 | Oct 2023 | £3.5m | £250.00 |
| Round 3 | Sep 2021 | £509k | £170.00 |
| Round 2 | Feb 2019 | £120k | £6,500.00 |
Showing the 6 most recent of 7 rounds.
Showing the 10 most recent of 106 filings.
See the complete cap table with every shareholder, founder tags, dilution across 40 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.